Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners

The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…

Christopher D. Payne net worth and biography

Christopher Payne Biography and Net Worth

Director of Hims & Hers Health

Christopher Payne has been a member of our Board of Directors since March 2024. He is a proven leader with more than three decades of software and technology experience. He previously served as the President and Chief Operating Officer of DoorDash from 2016 to 2023. Prior to his time at DoorDash, he served as the CEO of Tinder. He also served as Senior Vice President at eBay after he sold his company, Positronic, to the online retailer in 2008. Mr. Payne has also held leadership positions at Microsoft and Amazon, and currently serves on the board of directors of Gogo. He holds a B.A. in US History from Dartmouth College.

What is Christopher D. Payne's net worth?: The estimated net worth of Christopher D. Payne is at least $2.40 million as of May 22nd, 2024. Mr. Payne owns 110,000 shares of Hims & Hers Health stock worth more than $2,398,000 as of November 21st. This net worth approximation does not reflect any other assets that Mr. Payne may own. Learn More about Christopher D. Payne's net worth.
How do I contact Christopher D. Payne?: The corporate mailing address for Mr. Payne and other Hims & Hers Health executives is 2269 CHESTNUT STREET SUITE 523, SAN FRANCISCO CA, 94123. Hims & Hers Health can also be reached via phone at 415-851-0195 and via email at [email protected]. Learn More on Christopher D. Payne's contact information.
Has Christopher D. Payne been buying or selling shares of Hims & Hers Health?: Christopher D. Payne has not been actively trading shares of Hims & Hers Health during the last ninety days. Most recently, on Wednesday, May 22nd, Christopher D. Payne bought 110,000 shares of Hims & Hers Health stock. The stock was acquired at an average cost of $17.7433 per share, with a total value of $1,951,763.00. Following the completion of the transaction, the director now directly owns 110,000 shares of the company's stock, valued at $1,951,763. Learn More on Christopher D. Payne's trading history.
Who are Hims & Hers Health's active insiders?: Hims & Hers Health's insider roster includes Jack Abraham (Major Shareholder), Melissa Baird (COO), Soleil Boughton (Insider), Patrick Carroll (Insider), Michael Chi (Chief Commercial Officer), Andrew Dudum (Co-Founder, Chairman & CEO), Spencer Lee (CFO), Oluyemi Okupe (CFO), Christopher Payne (Director), and David Wells (Director). Learn More on Hims & Hers Health's active insiders.
Are insiders buying or selling shares of Hims & Hers Health?: In the last year, Hims & Hers Health insiders bought shares 3 times. They purchased a total of 115,000 shares worth more than $2,084,023.00. In the last year, insiders at the sold shares 80 times. They sold a total of 3,046,107 shares worth more than $53,170,215.84. The most recent insider tranaction occured on November, 18th when COO Melissa Baird sold 58,750 shares worth more than $1,236,100.00. Insiders at Hims & Hers Health own 17.7% of the company. Learn More about insider trades at Hims & Hers Health.
Information on this page was last updated on 11/18/2024.

Christopher D. Payne Insider Trading History at Hims & Hers Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
5/22/2024	Buy	110,000	$17.74	$1,951,763.00	110,000

Christopher D. Payne Buying and Selling Activity at Hims & Hers Health

Hims & Hers Health Company Overview

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.

Today's Range

Now: $21.80

$21.44

$23.12

50 Day Range

MA: $20.21

$15.82

$27.89

2 Week Range

Now: $21.80

$7.51

$30.44

Volume

18,369,969 shs

Average Volume

21,445,972 shs

Market Capitalization

$4.76 billion

P/E Ratio

49.55

Dividend Yield

N/A

Beta

1.06

Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners

From Colonial Metals | Ad

Claim your FREE 2024 Gold Guide